Showing 2131-2140 of 10440 results for "".
Take 5 With Peter Kang, CEO, CoolHealth
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/take-5-with-peter-kang-ceo-coolhealth-1/23926/Unify the United with Unity
https://practicaldermatology.com/topics/editorial/unify-united-unity/29187/Neal Bhatia, MD, Reflects on the nature of working together and unifying for the betterment of the dermatology profession.Process Control: How Chris' Cafe Relates to Medical Practice
https://practicaldermatology.com/topics/practice-management/process-control-how-chris-cafe-relates-to-medical-practice/21122/Reflections On a Year Unlike Any Other
https://practicaldermatology.com/topics/practice-management/reflections-on-a-year-unlike-any-other/23398/Change is good and other hard lessons from 2020.How Much Are You Leaving on the Table?
https://practicaldermatology.com/topics/practice-management/how-much-are-you-leaving-on-the-table/21444/How to improve your after-tax financial efficiency for 2014.The Importance of the Atopic Dermatitis Pipeline
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37148/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, provides an overview of important research underway involving new therapeutics for the treatment of atopTesting for Persistent Atopic Dermatitis in Pediatric Patients
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37151/Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the University of California, San Diego, School of Medicine, explains key considerations when testing for persistent atopic dermatitis in children.Psoriasis Therapeutics and Moving to Private Practice
https://practicaldermatology.com/series/the-practical-dermatology-podcast/program-name/35733/H.L. Greenberg, MD, discusses his recent Practical Dermatology article on the various benefits of different psoriasis therapeutics, and Tina Bhutani, MD, MAS, FAAD, joins Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, to discuss the transition from academia to private practice and playPractical Dermatology Roundtable: Generalized Pustular Psoriasis, Ch. 1
https://practicaldermatology.com/series/the-practical-dermatology-roundtable/practical-dermatology-roundtable-generalized-pustular-psoriasis-ch-1/32757/In the first installment of a six-part series, host Neal Bhatia, MD, FAAD, and guests Jason E. Hawkes, MD, MS, FAAD, and Laura K. Ferris, MD, PhD, FAAD, provide an overview of generalized pustular psoriasis, including the unique challenges it poses, triggers associated with it, and the importance ofDermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-3-year-clinical-data-lebrikizumab/28648/Study author Melinda Gooderham, MSc, MD, FRCPC, discusses the new three-year clinical data presented at the European Academy of Dermatology & Venereology (EADV) Congress on the efficacy and safety of lebrikizumab, which the FDA recently approved on September 13 for adults and adolescents with mo